234 related articles for article (PubMed ID: 19099586)
1. Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer.
Fritzsche FR; Weichert W; Röske A; Gekeler V; Beckers T; Stephan C; Jung K; Scholman K; Denkert C; Dietel M; Kristiansen G
BMC Cancer; 2008 Dec; 8():381. PubMed ID: 19099586
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.
Weichert W; Röske A; Gekeler V; Beckers T; Stephan C; Jung K; Fritzsche FR; Niesporek S; Denkert C; Dietel M; Kristiansen G
Br J Cancer; 2008 Feb; 98(3):604-10. PubMed ID: 18212746
[TBL] [Abstract][Full Text] [Related]
3. Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.
Weichert W; Röske A; Gekeler V; Beckers T; Ebert MP; Pross M; Dietel M; Denkert C; Röcken C
Lancet Oncol; 2008 Feb; 9(2):139-48. PubMed ID: 18207460
[TBL] [Abstract][Full Text] [Related]
4. HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma.
Ramakrishnan S; Ku S; Ciamporcero E; Miles KM; Attwood K; Chintala S; Shen L; Ellis L; Sotomayor P; Swetzig W; Huang R; Conroy D; Orillion A; Das G; Pili R
BMC Cancer; 2016 Aug; 16():617. PubMed ID: 27506904
[TBL] [Abstract][Full Text] [Related]
5. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M
Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133
[TBL] [Abstract][Full Text] [Related]
7. Expression of histone deacetylases 1, 2 and 3 in histological subtypes of testicular germ cell tumours.
Fritzsche FR; Hasler A; Bode PK; Adams H; Seifert HH; Sulser T; Moch H; Barghorn A; Kristiansen G
Histol Histopathol; 2011 Dec; 26(12):1555-61. PubMed ID: 21972094
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of class I histone deacetylases in human cancer tissues.
Nakagawa M; Oda Y; Eguchi T; Aishima S; Yao T; Hosoi F; Basaki Y; Ono M; Kuwano M; Tanaka M; Tsuneyoshi M
Oncol Rep; 2007 Oct; 18(4):769-74. PubMed ID: 17786334
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions.
Giaginis C; Alexandrou P; Delladetsima I; Giannopoulou I; Patsouris E; Theocharis S
Tumour Biol; 2014 Jan; 35(1):61-71. PubMed ID: 23873102
[TBL] [Abstract][Full Text] [Related]
10. Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma.
Adams H; Fritzsche FR; Dirnhofer S; Kristiansen G; Tzankov A
Expert Opin Ther Targets; 2010 Jun; 14(6):577-84. PubMed ID: 20415600
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
Giaginis C; Damaskos C; Koutsounas I; Zizi-Serbetzoglou A; Tsoukalas N; Patsouris E; Kouraklis G; Theocharis S
BMC Gastroenterol; 2015 Oct; 15():148. PubMed ID: 26502922
[TBL] [Abstract][Full Text] [Related]
12. Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha.
Qian DZ; Kachhap SK; Collis SJ; Verheul HM; Carducci MA; Atadja P; Pili R
Cancer Res; 2006 Sep; 66(17):8814-21. PubMed ID: 16951198
[TBL] [Abstract][Full Text] [Related]
13. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
Khan N; Jeffers M; Kumar S; Hackett C; Boldog F; Khramtsov N; Qian X; Mills E; Berghs SC; Carey N; Finn PW; Collins LS; Tumber A; Ritchie JW; Jensen PB; Lichenstein HS; Sehested M
Biochem J; 2008 Jan; 409(2):581-9. PubMed ID: 17868033
[TBL] [Abstract][Full Text] [Related]
14. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
[TBL] [Abstract][Full Text] [Related]
15. Class I histone deacetylase expression in the human cyclic endometrium and endometrial adenocarcinomas.
Krusche CA; Vloet AJ; Classen-Linke I; von Rango U; Beier HM; Alfer J
Hum Reprod; 2007 Nov; 22(11):2956-66. PubMed ID: 17728353
[TBL] [Abstract][Full Text] [Related]
16. HDAC expression and clinical prognosis in human malignancies.
Weichert W
Cancer Lett; 2009 Aug; 280(2):168-76. PubMed ID: 19103471
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
Mithraprabhu S; Kalff A; Chow A; Khong T; Spencer A
Epigenetics; 2014 Nov; 9(11):1511-20. PubMed ID: 25482492
[TBL] [Abstract][Full Text] [Related]
18. The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in endometriosis.
Samartzis EP; Noske A; Samartzis N; Fink D; Imesch P
Reprod Sci; 2013 Dec; 20(12):1416-22. PubMed ID: 23690335
[TBL] [Abstract][Full Text] [Related]
19. High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo.
Lehmann A; Denkert C; Budczies J; Buckendahl AC; Darb-Esfahani S; Noske A; Müller BM; Bahra M; Neuhaus P; Dietel M; Kristiansen G; Weichert W
BMC Cancer; 2009 Nov; 9():395. PubMed ID: 19912635
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy.
Khabele D; Son DS; Parl AK; Goldberg GL; Augenlicht LH; Mariadason JM; Rice VM
Cancer Biol Ther; 2007 May; 6(5):795-801. PubMed ID: 17387270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
